Background/aim: Compared with conventional pharmacological therapies, bariatric surgery has been shown to cause greater and- sustained weight loss. It was aimed to evaluate weight loss in obese patients after laparoscopic adjustable gastric banding surgery using information typically available during the initial evaluation studied before bariatric surgery and genes.
Methodology: 74 patients undergoing laparoscopic adjustable gastric banding (LAGB) were enrolled. Artificial Neural Network technology was used to predict weight loss.
Results: We studied 74 patients consisting of 22 men and 52 women 2 years after operation. Mean age was 31.7 +/- 9.1 years. 27 (36.5%) patients had successful weight reduction (excess weight loss >50%) while 47 (63.5%) did not. ANN provided predicted factors on gender, insulin, albumin and two genes: re4684846_r, rs660339_r which were associated with success.
Conclusion: Artificial neural network is a better modeling technique and the predictive accuracy is higher on the basis of multiple variables related to laboratory tests. Our finding gave demonstrated result that obese patients of successful weight reduction after laparoscopic adjustable gastric banding surgery were women, having little lower insulin and albumin, and carrying GG genotype on rs4684846 and with at least one T allele on rs660339. In these cases, weight loss will give better results.
Download full-text PDF |
Source |
---|
Obes Surg
December 2024
Division of Gastroenterology, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea.
Laparoscopic adjustable gastric banding (LAGB) is a type of bariatric surgery. Gastric stenosis or obstruction is a known complication of LAGB; however, its occurrence after band removal is extremely rare. A 60-year-old female, who had undergone LAGB 6 years earlier and band removal 4 years prior, presented to the hospital with recurrent vomiting.
View Article and Find Full Text PDFCurr Urol Rep
November 2024
Department of Urology, Indiana University, 11725 North Illinois Street - Carmel, Indianapolis, IN, IN - 46032, United States of America.
Cureus
October 2024
Surgery Department, Hospital Zambrano Hellion TecSalud, San Pedro Garza García, MEX.
Obesity has been recognized as the main pandemic of this century. Multiple treatments have been developed: the use of medications, exercise, diet, and surgery. Bariatric surgery is one of the treatments that has shown the greatest effectiveness.
View Article and Find Full Text PDFSurg Obes Relat Dis
January 2025
Minimally Invasive Bariatric & General Surgery, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio. Electronic address:
Background: Metabolic and bariatric surgery is a safe and effective treatment strategy for severe childhood obesity, affecting 10% of US adolescents.
Objectives: This prospective observational study addresses knowledge gaps related to changes in weight, cardiometabolic risk, and weight-related quality of life (WRQOL) in adolescents 10 years after laparoscopic adjustable gastric band (LAGB) insertion.
Setting: Five Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) US centers.
Int J Obes (Lond)
November 2024
Department of Endocrinology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Background: Endoscopic bariatric surgery (EBS) is a new treatment for obesity. We compared the efficacy, safety, and probability of metabolic complications of different EBSs with laparoscopic sleeve gastrectomy (LSG).
Methods: This systematic review and network meta-analysis (NMA) included searches of PubMed, Web of Science, and the Cochrane Library from January 1, 2017, to December 27, 2022, to find comparative trials of EBS procedures and EBS with LSG.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!